HIGH-VOLUME PLASMAPHERESIS IN CARDIAC AND AORTIC SURGERY
https://doi.org/10.21292/2078-5658-2018-15-2-25-31
Abstract
Prevention and treatment of multi-organ failure after complicated surgeries on heart and major vessels remain to be crucial.
The objective: to evaluate the potential use and efficiency of high-volume plasmapheresis for prevention and early therapy of multiple organ failure syndrome.
Methods: high-volume plasmapheresis was used in 246 patients with the most disseminated complications of the peri-operative period. Plasmapheresis was done during the first 4–6 hours after surgery (157 patients) and in 6–12 hours after surgery (41 patients) and later than 12 hours (48 patients).
Results. After complicated surgeries with in vitro hemoperfusion, the activation of system inflammatory response and endotoxicosis was more intensive versus patients with no complications. Plasmapheresis in 4–6 hours after surgery promoted metabolic normalization and in the majority of cases prevented of multiple organ failure (if at least 50% of circulating plasma was removed). After early plasmapheresis, the level of markers of system inflammatory response and endotoxicosis reduced by 28–30%, which allowed preventing serious renal disorders and cytolysis manifestations.
Conclusion: Post-operative high-volume plasmapheresis performed in 4–6 hours after complicated cardiac surgeries is effective for prevention of multiple organ failure syndrome in 64% of cases.
About the Authors
I. N. Solovievа
B. V. Petrovsky Russian Research Surgery Center
Russian Federation
Russian Federation
Irina N. Solovieva – Candidate of Medical Sciences, Head of Laboratory for Transfusiology with Expedition
2, Abrikosovsky Lane, Moscow, 119992
Yu. V. Belov
B. V. Petrovsky Russian Research Surgery Center
Russian Federation
Russian Federation
Yury V. Belov – Doctor of Medical Sciences, Professor, Academician of RAS, Director
2, Abrikosovsky Lane, Moscow, 119992
References
1. Babaev M.А. Sindrom poliorgannoy nedostatochnosti posle serdechno-sosudistykh operatsiy v usloviyakh iskusstvennogo krovoobrascheniya. Diss. dokt. med. nauk. [Multiple organ failure syndrome after cardiac-vascular surgeries with cardiopulmonary bypass. Doct. Diss.]. Moscow, 2011, 46 p.
2. Belov Yu.V., Katkov А.I., Vinokurov I.А. et al. The duration of cardiopulmonary bypass as a predictor of early outcomes after cardiac surgery. Khirurgiya. Journal im. N. I. Pirogova, 2015, vol. 5, pp. 4-13. (In Russ.)
3. Bokeriya L.А., Samuilova D.Sh., Аverina T.B. et al. System inflammatory response syndrome in cardiac surgery patients (review). Serdechno-Sosudistye Zabolevaniya, 2004, vol. 5, no. 12, pp. 5-24. (In Russ.)
4. Eremenko A.A. Osnovy posleoperatsionnoy intensivnoy terapii v khirurgii aorty. [Basics of post-operative intensive care in aorta surgeries]. In: Belov Yu.V., Komarov R.N. Rukovodstvo po khirurgii torakoabdominalnykh anevrizm aorty. [Guidelines on surgery of thoracic-abdominal aortic aneurysm]. Moscow, OOO Meditsinskoye informatsionnoye agentstvo Publ., 2010. pp. 186-226. (In Russ.)
5. Ermakova L.P. Sostoyanie immunnoy sistemy u kardiokhirurgicheskikh bolnykh pri iskusstvennom krovoobraschenii i vnutriaortalnoy ballonnoy kontrpulsatsii. Diss. kand. med. nauk. [State of immune system in the patients undergoing cardiac surgery with cardiopulmonary bypass and intra-aortic balloon counterpulsation. Cand. Diss.]. Moscow, 2001, 27 p.
6. Zatsepina N.E. Vliyanie iskusstvennogo krovoobrashheniya na perekisnoe okislenie lipidov. Diss. kand. med. nauk. [Impact of cardiopulmonary bypass on lipid peroxidation. Cand. Diss.]. Moscow, 2001, 124 p.
7. Lifshits V.M., Sidelnikova V.I. Meditsinskie laboratornye analizy. [Medical laboratory tests]. Moscow, Triada-X Publ., 2003, 312 p.
8. Lobacheva G.V. Faktory riska razvitiya rannikh oslozhneniy i ikh korrektsiya u bolnykh posle operatsiy na otkrytom serdtse. Diss. dokt. med. nauk. [Risk factors of early complications and their management in the patients after open heart surgery. Doct. Diss.]. Moscow, 2000, 44 p.
9. Loginov S.P., Trefilova O.А. Use of combined methods of in vitro management and approaches to selection of technologies in multiple organ failure. Trudy devyatoy konferentsii Moskovskogo obschestva gemafereza. [Abst. book of the 9th Conference of Moscow Hemapheresis Society]. Moscow, 2001, pp. 104. (In Russ.)
10. Acute renal failure. Nefrologiya i Dializ, 2015, vol. 3, no. 17, pp. 287-293. (In Russ.)
11. Petrischev Yu.I., Lebedeva S.S., Sharipov А.M. et al. Syndrome of system inflammatory response as a cause o complicated post-operative course in cardiac surgery. Infeksii v Khirurgii, 2014, no. 4, pp. 37-39. (In Russ.)
12. Plotnikov G.P. Strategiya rannego intensivnogo lecheniya poliorgannoy nedostatochnosti posle kardiokhirurgicheskikh vmeshatelstv. Diss. dokt. med. nauk. [Strategy of early intensive care of multiple organ failure after cardiac surgery. Doct. Diss.]. Moscow, 2010.
13. Radivilko A.S. Prevention of complications after surgeries with cardiopulmonary bypass. Kompleksnye Problemy Serdechno-Sosudistykh Zabolevaniy, 2016, vol. 5, no. 3, pp. 117-123. (In Russ.)
14. Serebryakova E.N., Volosnikov D.K., Glazyrina G.А. Multi organ failure syndrome: current understanding of the problem. Vestn. Anesteziologii I Reanimatologii, 2013, vol. 10, no. 5, pp. 60-65. (In Russ.)
15. Solovieva I.N. Plazmaferez posle operatsiy na aorte i magistralnykh sosudakh. [Plasmapheresis after aortic and major vascular surgeries]. In: Belov Yu.V., Komarov R.N. Rukovodstvo po khirurgii torakoabdominalnykh anevrizm aorty. [Guidelines on surgery of thoracic-abdominal aortic aneurysm]. Moscow, OOO Meditsinskoye informatsionnoye agentstvo Publ., 2010. pp. 141-153. (In Russ.)
16. Solovieva I.N., Ragimov А.А. Plasmapheresis in intensive care. Efferentnaya i Fiziko-Khimicheskaya Meditsina, 2011, no. 1, pp. 43-49. (In Russ.)
17. Solovieva I.N., Ragimov А.А., Eremenko А. А. et al. Plasmapheresis in emergency in a surgical practice. Transfuziologiya v Reanimatologii, 2005, pp. 465-509. (In Russ.)
18. Yarustovskiy M.B. Modern methods of intoxication in the post-operative period in the intensive care unit. Annaly Khirurgii, 2013, no. 2, pp. 13-21. (In Russ.)
19. Yarustovskiy M.B., Аbramyan M.V., Komardina E.V. et al. In vitro methods of hemocorrections in acute renal failure in those after cardiac surgery. Anesteziologiya i Reanimatologiya, 2014, no. 5, pp. 4-10. (In Russ.)
20. Yarustovskiy M.B., Аbramyan M.V., Krotenko N.P. et al. Methods of molecular transfusiology in intensive care of critical states. Vestn. Ros. Ak. Med. Nauk., 2016, vol. 71, no. 4, pp. 281-287. (In Russ.)
21. Bauer T.T., Monton C., Torres A. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrom, sever pneumonia and controls. Thorax, 2000, vol. 55, suppl. 1), pp. 46-52.
22. Bone R.S. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome. What we do and do not know about cytokine regulation. Crit. Care Med., 1996, vol. 24, pp. 163-170.
23. Bone R.S. Sir Isaak Newton, sepsis, SIRS and CARS. Crit. Care Med., 2000, vol. 24, no. 7, pp. 1125-1128.
24. Ciurana C.L.E., Hack C.E. Molecular Mechanisms of Complement Activation during Ischemia and Reperfusion. Yearbook of Intensive Care and Emergency Medicine. Ed. by J.L.Vincent. 2002, Springer-Verlag, Berlin Heidelbelg New York. pp. 39-49.
25. Sabloizki A., Stenke T., Schrubert S. et al. Serum cytokine levels as predictors of fatal outcome of severe sepsis folowing cardiovascular surgery. 1-st International Congress «Sepsis and Multyorgan Dysfunction». 2003, pp. 8.
26. Sauaia A., Moore F.A., Moore E.E. et al. Early risk factors for postinjury multiple organ failure. World J. Surg., 1996, vol. 20, pp. 392-400.
27. Schwartr J., Winters J.L., Padmanabhan A. et al. Guidelines on the use of therapeutic apheresis in clinical practice – еvidenсе-based approach from the writing committee of the american society for apheresis: the sixth special issue. J. Clin. Aph., 2013, vol.
28. , pp. 145-284. 28. Schwartr J., Padmanabhan A., Aqui N. et al. Guidelines on the use of therapeutic apheresis in clinical practice – еvidenсе-based approach from the writing committee of the american society for apheresis: the seventh special issue. J. Clin. Aph., 2016, vol. 31, issue 3, pp. 149-338.
29. Szczepirkowski Z.M., Winters J.L., Bandarenco N. et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the apheresis applications committee of the american society for apheresis. J. Clin. Apheresis ASFA, 2010, vol. 25, issue 3, pp. 83-177.
30. Taniguchi T., Koido Y., Aibosti J. et al. Change in the ratio of IL-6 to IL-10 predicts a poor outcome with patients SIRS. Crit. Cаre Med., 1999, vol. 27, pp. 1262-1264.
31. Therapeutic Plasmapheresis (XYI). Proceedings of the first international conference for apheresis. Japanese Journal of Apheresis, 1997, vol. 16, no. 1, URL: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1744-9987/issues
32. Vercamest L. Hemolysis in cаrdiac surgery patients undergoing cfrdiopulmonary bypass: A review in search of a treatment algorithm. J. Extra Corporeal Techology, 2008, vol. 40, no. 4, pp. 257-267.
33. Vincent J.L. Prevention and therapy of multiple organ failure. World J. Surg., 1996, vol. 20, pp. 465-470.
Review
For citations:
Solovievа I.N., Belov Yu.V. HIGH-VOLUME PLASMAPHERESIS IN CARDIAC AND AORTIC SURGERY. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2018;15(2):25-31. (In Russ.) https://doi.org/10.21292/2078-5658-2018-15-2-25-31
Email this article 